Stocks to Buy based on the Best Stock Market Research
Found another terrible undervalued which trading below Cash and which is close to phase 3 readout if successfull the drug will have around $600+ M Market Potential . The Company has only 7.5 Million…Continue
Started Oct 3, 2017
MDNA.TO (MC C$36 M) (Cash C$20 M) Hot Cancer Play with important Results in Q1 that could lead to FDA approval =1500-2000% UPSIDE Potential ! Brutally cheap and completely unknown canadian biotech…Continue
Started this discussion. Last reply by John James Sep 21, 2017.
SNOA (MC $23 M)(Cash $13 M) Shares Out 4.3 M / Lots of Marketed Products some of them are in early launch phase plus additional Product launches expected within 6 months / Revenue close to hit $16…Continue
Started this discussion. Last reply by John James Oct 31, 2017.
another super hot and dirt cheap FDA playKTOV (MC $16 M) (Cash $17 M) US-NDA Submission for their osteoarthritis pain and hypertension drug exptected this Quarter. This ultra low float stock will be…Continue
Started this discussion. Last reply by Edsion Wang Nov 20, 2017.